PL1931704T3 - Wytwarzanie i oczyszczanie IL-29 - Google Patents

Wytwarzanie i oczyszczanie IL-29

Info

Publication number
PL1931704T3
PL1931704T3 PL06816409T PL06816409T PL1931704T3 PL 1931704 T3 PL1931704 T3 PL 1931704T3 PL 06816409 T PL06816409 T PL 06816409T PL 06816409 T PL06816409 T PL 06816409T PL 1931704 T3 PL1931704 T3 PL 1931704T3
Authority
PL
Poland
Prior art keywords
methods
production
purification
coli
vectors
Prior art date
Application number
PL06816409T
Other languages
English (en)
Inventor
Bruce L Zamost
Geoffrey F Lee
Robert M Dedinsky
Original Assignee
Zymogenetics L L C
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C
Publication of PL1931704T3 publication Critical patent/PL1931704T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06816409T 2005-10-04 2006-10-04 Wytwarzanie i oczyszczanie IL-29 PL1931704T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72354405P 2005-10-04 2005-10-04
PCT/US2006/039139 WO2007041713A1 (en) 2005-10-04 2006-10-04 Production and purification of il-29
EP06816409A EP1931704B1 (en) 2005-10-04 2006-10-04 Production and purification of il-29

Publications (1)

Publication Number Publication Date
PL1931704T3 true PL1931704T3 (pl) 2011-06-30

Family

ID=37603659

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06816409T PL1931704T3 (pl) 2005-10-04 2006-10-04 Wytwarzanie i oczyszczanie IL-29

Country Status (15)

Country Link
US (6) US20080096252A1 (pl)
EP (1) EP1931704B1 (pl)
JP (3) JP5364375B2 (pl)
AT (1) ATE491722T1 (pl)
AU (1) AU2006299339B2 (pl)
CA (1) CA2625208A1 (pl)
CY (1) CY1112323T1 (pl)
DE (1) DE602006018969D1 (pl)
DK (1) DK1931704T3 (pl)
ES (1) ES2357152T3 (pl)
IL (2) IL189994A (pl)
PL (1) PL1931704T3 (pl)
PT (1) PT1931704E (pl)
SI (1) SI1931704T1 (pl)
WO (1) WO2007041713A1 (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026265A2 (en) 2000-09-29 2002-04-04 Schering Corporation Pegylated interleukin-10
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
ES2303132T3 (es) * 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
US20070053933A1 (en) * 2005-07-20 2007-03-08 Sheppard Paul O IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
DE602006018969D1 (de) 2005-10-04 2011-01-27 Bristol Myers Squibb Co Herstellung und reinigung von il-29
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
RU2562108C2 (ru) * 2007-09-20 2015-09-10 Коммонвелт Сайентифик Энд Индастриал Рисерч Органайзейшн Новые цитокины птиц и кодирующие их генетические последовательности
EP2245044A2 (en) * 2008-01-18 2010-11-03 F. Hoffmann-La Roche AG Purification of non-glycosylated proteins
CA2727026A1 (en) * 2008-06-05 2009-12-10 Zymogenetics, Llc Use of pegylated type iii interferons for the treatment of hepatitis c
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
JP5888980B2 (ja) 2008-12-17 2016-03-22 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． モノ−およびジ−ｐｅｇｉｌ１０の製造および用途
EP2417246A4 (en) * 2009-04-10 2015-11-04 Reg Life Sciences Llc PRODUCTION OF FATTY ACID DERIVATIVES
WO2011098644A2 (es) 2010-02-09 2011-08-18 Proyecto De Biomedicina Cima, S.L. Composiciones para el tratamiento de enfermedades infecciosas y tumorales
JP5768341B2 (ja) * 2010-08-04 2015-08-26 東ソー株式会社 Ｆｃ結合性タンパク質の製造方法
CN102584979B (zh) * 2011-01-18 2015-10-14 北京凯因科技股份有限公司 PEG化干扰素λ
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CN103228792A (zh) * 2011-08-25 2013-07-31 纳诺亘医药生物科技公司 PEG-干扰素λ1结合物
US8454947B1 (en) 2012-03-01 2013-06-04 Nanogen Pharmaceutical Biotechnology PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) * 2013-03-11 2016-08-10 中国医学科学院基础医学研究所 PEG化重组人IFN-λ1、其制备方法和用途
AU2014254019B2 (en) 2013-04-18 2018-09-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US20160159853A1 (en) * 2013-07-19 2016-06-09 Biogenomics Limited Apparatus for refolding of recombinant proteins
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
MX2016005915A (es) 2013-11-11 2016-12-16 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
CN104968673B (zh) * 2014-01-08 2018-11-02 德益阳光生物技术（北京）有限责任公司 融合多肽及使用方法
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
AU2015333827A1 (en) 2014-10-14 2017-04-20 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
ES2941234T3 (es) 2014-10-22 2023-05-19 Armo Biosciences Inc Métodos de uso de la interleucina-10 para el tratamiento de enfermedades y trastornos
EP3237441A4 (en) * 2014-12-23 2018-06-06 Armo Biosciences, Inc. Methods of improving yield in recombinant protein production
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
HUE054068T2 (hu) 2015-04-21 2021-08-30 Eiger Biopharmaceuticals Inc Lonafarnibot és Ritonavirt tartalmazó gyógyszerkészítmények
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
AU2016312510A1 (en) 2015-08-25 2018-03-08 Armo Biosciences, Inc. Methods of using Interleukin-10 for treating diseases and disorders
PL3416675T3 (pl) 2016-02-19 2021-10-11 Eiger Biopharmaceuticals, Inc. Leczenie zakażenia wirusem zapalenia wątroby typu delta za pomocą interferonu lambda
TWI763732B (zh) 2016-11-07 2022-05-11 美商西雅圖遺傳學公司 工程化半胱胺酸帽之分佈
JP7487951B2 (ja) * 2019-02-24 2024-05-21 オンコシミス バイオテック プライベート リミテッド 細菌による組換えｇｌｐ－１ペプチドの連続生産方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795077A (en) * 1988-05-23 1989-01-03 Motorola Inc. Bonding method and apparatus
EP0626448A3 (de) 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
AU2346900A (en) * 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
CN100448993C (zh) * 2000-06-30 2009-01-07 津莫吉尼蒂克斯公司 干扰素样蛋白质Zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
AU2003286624B2 (en) * 2002-10-23 2008-11-13 Bristol-Myers Squibb Company Methods for treating viral infection using IL-28 and IL-29
JP4664684B2 (ja) * 2002-12-13 2011-04-06 ザイモジェネティクス， インコーポレイテッド 原核生物宿主におけるｉｌ−２１の生産
ES2303132T3 (es) * 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
JP4896005B2 (ja) 2004-04-02 2012-03-14 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法
CA2574564C (en) * 2004-07-29 2013-04-16 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer and autoimmune disorders
CN1305902C (zh) * 2004-11-25 2007-03-21 汕头大学医学院 一种人白细胞介素29的生产方法及重组il－29工程菌
PL1828239T3 (pl) * 2004-12-10 2012-01-31 Zymogenetics Inc Produkcja FGF18 w organizmach prokariotycznych
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
DE602006018969D1 (de) 2005-10-04 2011-01-27 Bristol Myers Squibb Co Herstellung und reinigung von il-29

Also Published As

Publication number Publication date
SI1931704T1 (sl) 2011-04-29
IL227691A0 (en) 2013-09-30
IL189994A (en) 2013-08-29
ES2357152T3 (es) 2011-04-19
JP2012235789A (ja) 2012-12-06
US20100003722A1 (en) 2010-01-07
JP2009510173A (ja) 2009-03-12
US8211670B2 (en) 2012-07-03
CY1112323T1 (el) 2015-12-09
WO2007041713A1 (en) 2007-04-12
CA2625208A1 (en) 2007-04-12
IL189994A0 (en) 2008-08-07
EP1931704A1 (en) 2008-06-18
US7968315B2 (en) 2011-06-28
US20120271037A1 (en) 2012-10-25
PT1931704E (pt) 2011-03-28
AU2006299339A1 (en) 2007-04-12
ATE491722T1 (de) 2011-01-15
US8759027B2 (en) 2014-06-24
JP2013099337A (ja) 2013-05-23
DE602006018969D1 (de) 2011-01-27
DK1931704T3 (da) 2011-03-14
US20130143270A1 (en) 2013-06-06
US20080096252A1 (en) 2008-04-24
EP1931704B1 (en) 2010-12-15
US20120015403A1 (en) 2012-01-19
JP5364375B2 (ja) 2013-12-11
AU2006299339B2 (en) 2012-03-15
US7759092B2 (en) 2010-07-20
US20100222552A1 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
IL227691A0 (en) Creation and purification of 29 – il
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
SG10201407329RA (en) Modified vasoactive intestinal peptides
PL1948789T3 (pl) Sposób wytwarzania ciągłych ludzkich linii komórkowych
MX2012006096A (es) Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos.
MX2009012846A (es) Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
CA2782424C (en) Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
MX2012015142A (es) Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo.
MY187542A (en) Carbohydrate degrading polypeptide and uses thereof
EP3805348A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
MX2012003473A (es) Polipeptidos que tienen actividad celulitica mejorada y polinucleotidos que codifican para los mismos.
CL2007001335A1 (es) Anticuerpo anti cd40; acido nucleico que lo codifica; celula; cultivo celular; metodo de produccion; composicion farmaceutica; metodo para seleccionar un anticuerpo anti cd40; y su uso para tratar sintomas de un trastorno autoinmune y/o un trastorno inflamatorio y/o para reducir el rechazo al injerto y/o para el tratamiento de cancer positivos a cd40.
WO2010099477A3 (en) Polypeptide structural motifs associated with cell signaling activity
MX2011010494A (es) Polipeptidos que tienen actividad de celulasa.
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
SI1941027T1 (sl) Postopki in sredstva za proliferacijo zarodnih celic in kasnejšo generacijo in ekspanzijo progenitorskih celic, kot tudi izdelava efektor celic kot kliničnih zdravil
UA95083C2 (ru) Азеотропная или близкая к азеотропной композиции, которые содержат 1,1,1,2,3-пентафторопропен и фтороводород, способы отделения и получения 1,1,1,2,3-пентафторопропена
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
ATE521633T1 (de) Fgf18 produktion in prokaryotischen zellen
AU2003223124A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
BR112012017243A2 (pt) constructos terapêuticos de apirase, agentes de apirase, e métodos de produção
TW200633948A (en) Composites and methods for the manufacture and use thereof
AU2002304249A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
MX2007005520A (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican los mismos.
TW200734350A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same